News

Symbiosis Pharmaceutical Services, has launched new in-house analytical and microbiological capabilities to enable testing of small molecule, biological, and Advanced...

Symbiosis has today announced a 1 million GBP (1.2 million Euros, 1.3 million USD) investment in its in-house analytical services...

We are pleased to announce the launch of our new video of the GMP manufacturing facility here at Symbiosis in...

Symbiosis announces the completion of a £1.3 million collaborative UKRI-funded project as part of the medicines manufacturing challenge. Symbiosis and...

Symbiosis is delighted to announce an expansion of its capabilities to handle novel and emerging treatments, such as viral based...

We’re very proud to announce that Symbiosis is working with Modus Therapeutics Holding AB, a company developing innovative treatments for...

Symbiosis Pharmaceutical Services (Symbiosis), a fast-growing Contract Manufacturing Organisation (CMO) specialising in sterile manufacture of vaccines, pharmaceuticals, and biopharmaceuticals, and...

Amazing news for everyone with the confirmation that AstraZeneca’s COVID-19 vaccine has been approved for emergency supply in the UK...

Symbiosis CEO Colin MacKay is a proud member of the ILG (Life Sciences Industry Leadership Group) and they have just...

We were delighted to see Symbiosis apprentices showcased in The Sunday Times yesterday. The Scottish Government has identified apprenticeships as...

Fantastic news for everyone as a vaccine that Symbiosis has supported is hailed as a “vaccine for the whole world”....

RAPIDLY-GROWING contract manufacturing organisation (CMO) Symbiosis Pharmaceutical Services (Symbiosis), has successfully completed a scheduled inspection by the UK Government regulator,...